Chemours Co

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $7.0m $746.0m $995.0m ($52.0m) $219.0m $608.0m $578.0m ($238.0m) $86.0m ($386.0m)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $7.0m $747.0m $996.0m ($52.0m) $219.0m $608.0m $578.0m ($237.0m) $86.0m ($386.0m)
Net Income (Loss) Attributable to Noncontrolling Interest $0 $1.0m $1.0m $0 $0 ($1.0m)
Depreciation, Depletion and Amortization $284.0m $273.0m $284.0m $311.0m $320.0m $317.0m $291.0m $307.0m $301.0m $340.0m
Amortization of Debt Issuance Costs and Discounts $20.0m $13.0m $11.0m $9.0m $9.0m $9.0m $9.0m $9.0m $12.0m $11.0m
Amortization of Intangible Assets $1.0m $1.0m
Depreciation $281.0m $269.0m $276.0m $304.0m $313.0m $309.0m $286.0m $297.0m $301.0m $340.0m
Deferred Income Tax Expense (Benefit) ($111.0m) $83.0m $22.0m ($163.0m) ($120.0m) ($76.0m) $20.0m ($158.0m) ($27.0m) $60.0m
Share-based Payment Arrangement, Noncash Expense $19.0m $16.0m $34.0m $27.0m $18.0m $15.0m $21.0m
Payment, Tax Withholding, Share-based Payment Arrangement $12.0m $17.0m $30.0m $2.0m $2.0m $6.0m $19.0m $3.0m $1.0m
Share-based Payment Arrangement, Expense $20.0m $29.0m $24.0m $19.0m $16.0m $34.0m $27.0m $18.0m $15.0m $21.0m
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0 $0 $0 $56.0m $0
Restructuring Costs and Asset Impairment Charges $124.0m $3.0m $4.0m $43.0m $22.0m $0 $5.0m $95.0m $27.0m $32.0m
Gain (Loss) on Disposition of Assets $254.0m $22.0m $45.0m $10.0m $8.0m $115.0m $21.0m $110.0m $3.0m $8.0m
Gain (Loss) on Extinguishment of Debt ($6.0m) $1.0m ($38.0m) $0 ($22.0m) ($21.0m) $7.0m ($1.0m) ($1.0m) ($5.0m)
Income (Loss) from Equity Method Investments $29.0m $33.0m $43.0m $29.0m $23.0m $43.0m $55.0m $45.0m $43.0m $35.0m
Income Tax Expense (Benefit) ($18.0m) $165.0m $159.0m ($72.0m) ($40.0m) $68.0m $163.0m ($81.0m) $41.0m $109.0m
Other Nonoperating Income (Expense) $247.0m $79.0m $162.0m ($293.0m) $21.0m $163.0m $70.0m $91.0m $8.0m $26.0m
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions $12.0m $33.0m ($18.0m) $3.0m $0 $11.0m $22.0m ($11.0m) $1.0m $7.0m
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Payable ($72.0m) ($9.0m) ($165.0m)
Asset Retirement Obligation, Accretion Expense $2.0m $6.0m $10.0m $7.0m $4.0m $2.0m $10.0m $3.0m
Environmental Remediation Expense $44.0m $48.0m $36.0m $200.0m $71.0m $269.0m $269.0m $66.0m $70.0m $123.0m
Goodwill $153.0m $153.0m $153.0m $102.0m $102.0m $102.0m $46.0m $46.0m
Inventory Write-down ($40.0m) $7.0m
Operating Expenses $1.2b $739.0m $788.0m $715.0m $700.0m $705.0m $844.0m $1.6b $810.0m $966.0m
Proceeds from Contributions from Parent $0
Proceeds from Stock Options Exercised $11.0m $31.0m $16.0m $9.0m $16.0m $23.0m $51.0m $19.0m $9.0m
Net Cash Provided by (Used in) Operating Activities $594.0m $639.0m $1.1b $650.0m $807.0m $820.0m $754.0m $556.0m ($633.0m) $264.0m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $338.0m $411.0m $498.0m $481.0m $267.0m $277.0m $307.0m $370.0m $360.0m $213.0m
Payments to Acquire Businesses, Net of Cash Acquired $37.0m $10.0m $0 $0
Payments for (Proceeds from) Other Investing Activities $0 $13.0m ($6.0m) ($2.0m) ($1.0m)
Net Cash Provided by (Used in) Investing Activities $357.0m ($370.0m) ($487.0m) ($483.0m) ($234.0m) $220.0m ($284.0m) ($229.0m) ($353.0m) ($206.0m)
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt $0 $495.0m $520.0m $0 $650.0m $0 $648.0m $606.0m $748.0m
Repayments of Long-term Debt $381.0m $27.0m $679.0m
Payments for Repurchase of Common Stock $106.0m $644.0m $322.0m $0 $173.0m $495.0m $69.0m
Payments of Ordinary Dividends, Common Stock $22.0m $22.0m $148.0m $164.0m $164.0m $164.0m $154.0m $149.0m $148.0m $78.0m
Proceeds from (Payments to) Noncontrolling Interests $1.0m ($1.0m)
Dividends Payable, Current $31.0m
Dividends Payable $31.0m $0 $0
Proceeds from (Payments for) Other Financing Activities $21.0m $21.0m
Net Cash Provided by (Used in) Financing Activities ($396.0m) $353.0m ($993.0m) ($419.0m) ($449.0m) ($560.0m) ($685.0m) $172.0m ($36.0m) ($126.0m)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $32.0m ($15.0m) ($6.0m) $38.0m ($34.0m) ($32.0m) $4.0m ($22.0m) $29.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $32.0m ($15.0m) ($258.0m) $162.0m $446.0m ($247.0m) $503.0m ($1.0b) ($39.0m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $32.0m ($15.0m) $943.0m $1.1b $1.6b $1.3b $1.8b $763.0m $724.0m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $206.0m $204.0m $208.0m $180.0m $164.0m $223.0m $267.0m $251.0m
Income Taxes Paid, Net $50.0m $79.0m $75.0m $85.0m $78.0m $149.0m $131.0m $54.0m $73.0m $74.0m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.